Research and Education
Scientific publishing
Research
Scientific publishing
2021
Detecting Resistance to Therapeutic ALK Inhibitors in Tumor Tissue and Liquid Biopsy Markers: An Update to a Clinical Routine Practice
Cells.
Hofman P.
2021 Jan 15;10(1):168.
New technologies for improved relevance in miRNA research.
Trends Genet.
Jacquet K, Vidal-Cruchez O, Rezzonico R, Nicolini VJ, Mograbi B, Hofman P, Vassaux G, Mari B, Brest P.
2021 Dec;37(12):1060-1063.
EGFR Status Assessment for Better Care of Early Stage Non-Small Cell Lung Carcinoma: What Is Changing in the Daily Practice of Pathologists?
Cells.
Hofman P.
2021 Aug 21;10(8):2157.
Histological pulmonary features due to the Sars-CoV-2
Rev Francoph Lab.
Hofman P, Copin MC.
2021 Jan;2021(528):30-35
New Targeted Therapies and Immunotherapies for Locally Advanced Periocular Malignant Tumours: Towards a New 'Eye-Sparing' Paradigm?
Cancers (Basel)
Martel A, Lassalle S, Picard-Gauci A, Gastaud L, Montaudie H, Bertolotto C, Nahon-Esteve S, Poissonnet G, Hofman P, Baillif S.
2021 Jun 5;13(11):2822
Perspectives and Issues in the Assessment of SMARCA4 Deficiency in the Management of Lung Cancer Patients.
Cells.
Armon S, Hofman P, Ilié M.
2021 Jul 29;10(8):1920.
COVID-19 vaccination and cancer immunotherapy: should they stick together?
Br J Cancer.
Brest P, Mograbi B, Hofman P, Milano G.
2022 Jan;126(1):1-3.
More light on cancer and COVID-19 reciprocal interaction.
Br J Cancer.
Brest P, Mograbi B, Hofman P, Milano G.
2021 Apr;124(8):1344-1345.
Prognostic Biomarkers in Uveal Melanoma: The Status Quo, Recent Advances and Future Directions.
Cancers (Basel).
Lamas NJ, Martel A, Nahon-Estève S, Goffinet S, Macocco A, Bertolotto C, Lassalle S, Hofman P.
2021 Dec 25;14(1):96.
Small but Challenging Conjunctival Melanoma: New Insights, Paradigms and Future Perspectives.
Cancers (Basel)
Nahon-Estève S, Bertolotto C, Picard-Gauci A, Gastaud L, Baillif S, Hofman P, Groulier A, Maschi C, Caujolle JP, Lassalle S, Martel A.
2021 Nov 14;13(22):5691.
Next-Generation Sequencing with Liquid Biopsies from Treatment-Naïve Non-Small Cell Lung Carcinoma Patients
Cancers (Basel)
Hofman P.
2021 Apr 23;13(9):2049.
Expert consensus on perioperative immunotherapy for local advanced non-small cell lung cancer.
Transl Lung Cancer Res.
Qiu B, Cai K, Chen C, Chen J, Chen KN, Chen QX, Cheng C, Dai TY, Fan J, Fan Z, Hu J, Hu WD, Huang YC, Jiang GN, Jiang J, Jiang T, Jiao WJ, Li HC, Li Q, Liao YD, Liu HX, Liu JF, Liu L, Liu Y, Long H, Luo QQ, Ma HT, Mao NQ, Pan XJ, Tan F, Tan LJ, Tian H, Wang D, Wang WX, Wei L, Wu N, Wu QC, Xiang J, Xu SD, Yang L, Zhang H, Zhang L, Zhang P, Zhang Y, Zhang Z, Zhu K, Zhu Y, Um SW, Oh IJ, Tomita Y, Watanabe S, Nakada T, Seki N, Hida T, Sasada S, Uchino J, Sugimura H, Dermime S, Cappuzzo F, Rizzo S, Cho WC, Crucitti P, Longo F, Lee KY, De Ruysscher D, Vanneste BGL, Furqan M, Sieren JC, Yendamuri S, Merrell KW, Molina JR, Metro G, Califano R, Bongiolatti S, Provencio M, Hofman P, Gao S, He J.
2021 Sep;10(9):3713-3736.
The Importance of STK11/LKB1 Assessment in Non-Small Cell Lung Carcinomas.
Diagnostics (Basel)
Mograbi B, Heeke S, Hofman P.
2021 Jan 29;11(2):196
To inhibit or to boost the ATP/P2RX7 pathway to fight cancer-that is the question.
Purinergic Signal
Janho Dit Hreich S, Benzaquen J, Hofman P, Vouret-Craviari V.
2021 Dec;17(4):619-631.
Using Genetics To Dissect SARS-CoV-2 Infection.
Trends Genet.
Brest P, Mograbi B, Hofman P, Milano G.
2021 Mar;37(3):203-204.
Orbital exenteration: an updated review with perspectives.
Surv Ophthalmol.
Martel A, Baillif S, Nahon-Esteve S, Gastaud L, Bertolotto C, Lassalle S, Lagier J, Hamedani M, Poissonnet G.
2021 Sep-Oct;66(5):856-876.
PD-L1 regulation revisited: impact on immunotherapeutic strategies.
Trends Mol Med.
Lucibello G, Mograbi B, Milano G, Hofman P, Brest P.
2021 Sep;27(9):868-881.
2020
Challenges and issues surrounding the use for translational research of human samples obtained during the COVID-19 pandemic from lung cancer patients.
Transl Lung Cancer Res.
Hofman P.
2020 Aug;9(4):1543-1553.